@article {Dryden-Peterson2020.11.02.20224469, author = {Scott Dryden-Peterson and Gustavo E. Vel{\'a}squez and Thomas J. Stopka and Sonya Davey and Shahin Lockman and Bisola Ojikutu}, title = {SARS-CoV-2 Testing Disparities in Massachusetts}, elocation-id = {2020.11.02.20224469}, year = {2020}, doi = {10.1101/2020.11.02.20224469}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Objective Early deficiencies in testing capacity contributed to poor control of transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In the context of marked improvement in SARS-CoV-2 testing infrastructure, we sought to examine the alignment of testing with epidemic intensity to mitigate subsequent waves of COVID-19 in Massachusetts.Methods We compiled publicly available weekly SARS-CoV-2 molecular testing data for period (May 27 to October 14, 2020) following the initial COVID-19 wave. We defined testing intensity as weekly SARS-CoV-2 tests performed per 100,000 population and used weekly test positivity (percent of tests positive) as a measure of epidemic intensity. We considered optimal alignment of testing resources to be matching community ranks of testing and positivity. In communities with a lower rank of testing than positivity in a given week, the testing gap was calculated as the additional tests required to achieve matching ranks. Multivariable Poisson modeling was utilized to assess for trends and association with community characteristics.Results During the observation period, 4,262,000 tests were reported in Massachusetts and the misalignment of testing with epidemic intensity increased. The weekly testing gap increased 9.0\% per week (adjusted rate ratio [aRR]: 1.090, 95\% confidence interval [CI]: 1.08-1.10). Increasing levels of community socioeconomic vulnerability (aRR: 1.35 per quartile increase, 95\% CI: 1.23-1.50) and the highest quartile of minority and language vulnerability (aRR: 1.46, 95\% CI 0.96-1.49) were associated with increased testing gaps, but the latter association was not statistically significant. Presence of large university student population (\>10\% of population) was associated with a marked decrease in testing gap (aRR 0.21, 95\% CI: 0.12-0.38).Conclusion These analyses indicate that despite objectives to promote equity and enhance epidemic control in vulnerable communities, testing resources across Massachusetts have been disproportionally allocated to more affluent communities. Worsening structural inequities in access to SARS-CoV-2 testing increase the risk for another intense wave of COVID-19 in Massachusetts, particularly among vulnerable communities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNational Institute of Allergy and Infectious Diseases at the National Institutes of Health (grant numbers K08 AI141740 and P30 AI060354), the Dr. Lynne Reid/Drs. Eleanor and Miles Shore Fellowship at Harvard Medical School, the Burke Global Health Fellowship at the Harvard Global Health Institute, and the Harvard University Center for AIDS Research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Analysis of public governmental data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and analysis code shared. https://github.com/sldrydenpeterson/MA-SARSCoV2-Testing-Alignment.git}, URL = {https://www.medrxiv.org/content/early/2020/11/04/2020.11.02.20224469}, eprint = {https://www.medrxiv.org/content/early/2020/11/04/2020.11.02.20224469.full.pdf}, journal = {medRxiv} }